| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Surface Oncology Inc (NASDAQ: SURF)
SURF Technical Analysis
5
| As on 9th Jun 2023 SURF STOCK Price closed @ 0.77 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.29 & Strong Sell for SHORT-TERM with Stoploss of 3.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SURFSTOCK Price
| Open | 0.79 | Change | Price | % |
| High | 0.81 | 1 Day | -0.01 | -1.28 |
| Low | 0.76 | 1 Week | -0.05 | -6.10 |
| Close | 0.77 | 1 Month | 0.19 | 32.76 |
| Volume | 208084 | 1 Year | -4.34 | -84.93 |
| 52 Week High 5.29 | 52 Week Low 0.57 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SURF Daily Charts |
SURF Intraday Charts |
Whats New @ Bazaartrend |
SURF Free Analysis |
|
|
SURF Important Levels Intraday
| RESISTANCE | 0.87 |
| RESISTANCE | 0.84 |
| RESISTANCE | 0.82 |
| RESISTANCE | 0.80 |
| SUPPORT | 0.74 |
| SUPPORT | 0.72 |
| SUPPORT | 0.70 |
| SUPPORT | 0.67 |
SURF Forecast May 2024
| 4th UP Forecast | 3.74 |
| 3rd UP Forecast | 2.79 |
| 2nd UP Forecast | 2.2 |
| 1st UP Forecast | 1.61 |
| 1st DOWN Forecast | -0.07 |
| 2nd DOWN Forecast | -0.66 |
| 3rd DOWN Forecast | -1.25 |
| 4th DOWN Forecast | -2.2 |
SURF Weekly Forecast
| 4th UP Forecast | 2.06 |
| 3rd UP Forecast | 1.65 |
| 2nd UP Forecast | 1.39 |
| 1st UP Forecast | 1.14 |
| 1st DOWN Forecast | 0.40 |
| 2nd DOWN Forecast | 0.15 |
| 3rd DOWN Forecast | -0.11 |
| 4th DOWN Forecast | -0.52 |
SURF Forecast2024
| 4th UP Forecast | 9.92 |
| 3rd UP Forecast | 6.99 |
| 2nd UP Forecast | 5.17 |
| 1st UP Forecast | 3.36 |
| 1st DOWN Forecast | -1.82 |
| 2nd DOWN Forecast | -3.63 |
| 3rd DOWN Forecast | -5.45 |
| 4th DOWN Forecast | -8.38 |
Surface Oncology Inc ( NASDAQ USA Symbol : SURF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SURF Business Profile
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 (IgG4) monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; SRF813 targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8 to deplete immuno-suppressive cells. It also develops an earlier stage program targeting regulatory T cells. The company has a strategic collaboration agreement with Novartis Institutes for Biomedical Research, Inc. for the development of cancer therapies; and a license agreement with GlaxoSmithKline to develop, manufacture, and commercialize antibodies that targets SRF813, as well as a clinical trial collaboration with Roche Holding AG to evaluate SRF388. Surface Oncology, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Address: 50 Hampshire Street, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service